The action of the RTK DDR2 in breast tumor stromal CAFs has been shown to contribute to the development of breast tumor stiffness by influencing ECM production and mechanical remodeling through control of full activation of collagen binding integrins (Bayer et al., 2019). The gene discussed is DDR2; the disease is breast neoplasm.